CYTK:NASDAQ
Cytokinetics, Inc.
$69.39
arrow_upward
+0.12%(+0.080) 1D
$69.39
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 16, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$69.52
High
$70.68
Low
$68.67
Mkt. cap
9.65B
Avg. vol.
1.88M
Volume
0.00
52-wk high
$88.31
52-wk low
$47.22
EPS
-$7.22
Beta
0.36
Shares outstanding
139.02M
No. of employees
673
Open
$69.52
High
$70.68
Low
$68.67
Mkt. cap
9.65B
Avg. vol.
1.88M
Volume
0.00
52-wk high
$88.31
52-wk low
$47.22
EPS
-$7.22
Beta
0.36
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
Stock Traders Daily
·
19 hours ago
Behavioral Patterns of CYTK and Institutional Flows
Investing.com
·
20 hours ago
Cytokinetics director Robert Landry sells $72,130 in shares
Investing.com
·
21 hours ago
Cytokinetics CEO Blum’s trust sells $6.7m in company shares
GuruFocus
·
1 day ago
Cytokinetics Inc (CYTK) Director Robert Landry Sells 1,000 Shares
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com